Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
- Conditions
- Stage I Kidney Wilms TumorStage II Kidney Wilms TumorStage III Kidney Wilms Tumor
- Interventions
- Radiation: 3-Dimensional Conformal Radiation TherapyProcedure: Biospecimen CollectionProcedure: Chest RadiographyProcedure: Computed TomographyProcedure: Echocardiography TestProcedure: Magnetic Resonance ImagingProcedure: Therapeutic Conventional SurgeryProcedure: Ultrasound Imaging
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 808
- Registration Number
- NCT00352534
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸USA Health Strada Patient Care Center, Mobile, Alabama, United States
Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
- Conditions
- Brain and Central Nervous System TumorsNeurofibromatosis Type 1
- Interventions
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 26
- Registration Number
- NCT00352495
- Locations
- 🇺🇸
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, United States
🇺🇸Children's Hospital of Orange County, Orange, California, United States
🇺🇸Children's National Medical Center, Washington, District of Columbia, United States
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
- Conditions
- Adult Extraskeletal OsteosarcomaAdult Malignant Fibrous HistiocytomaChildhood FibrosarcomaChildhood LiposarcomaMetastatic Childhood Soft Tissue SarcomaNonmetastatic Childhood Soft Tissue SarcomaStage I Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma
- Interventions
- Other: clinical observationProcedure: therapeutic conventional surgeryRadiation: 3-dimensional conformal radiation therapy
- First Posted Date
- 2006-06-29
- Last Posted Date
- 2022-04-28
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 588
- Registration Number
- NCT00346164
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Phoenix Childrens Hospital, Phoenix, Arizona, United States
🇺🇸University of Arizona Health Sciences Center, Tucson, Arizona, United States
Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma
- Conditions
- Intraocular Retinoblastoma
- Interventions
- First Posted Date
- 2006-06-12
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 331
- Registration Number
- NCT00335738
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of Arizona Health Sciences Center, Tucson, Arizona, United States
🇺🇸Children's Oncology Group, Arcadia, California, United States
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
- Conditions
- MedulloblastomaAnaplastic MedulloblastomaSupratentorial Embryonal Tumor, Not Otherwise SpecifiedUntreated Childhood Supratentorial Primitive Neuroectodermal Tumor
- Interventions
- Procedure: Autologous Hematopoietic Stem Cell TransplantationOther: Laboratory Biomarker AnalysisOther: Quality-of-Life Assessment
- First Posted Date
- 2006-06-12
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 91
- Registration Number
- NCT00336024
- Locations
- 🇺🇸
Tulane University School of Medicine, New Orleans, Louisiana, United States
🇺🇸Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States
🇺🇸NYU Langone Hospital - Long Island, Mineola, New York, United States
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
- Conditions
- Clear Cell Renal Cell CarcinomaChildhood Renal Cell CarcinomaClear Cell Sarcoma of the KidneyPapillary Renal Cell CarcinomaStage I Renal Cell CancerStage II Renal Cell CancerRhabdoid Tumor of the KidneyStage I Renal Wilms TumorStage IV Renal Wilms TumorStage II Renal Wilms Tumor
- Interventions
- Procedure: Conventional SurgeryBiological: DactinomycinOther: Laboratory Biomarker AnalysisRadiation: Radiation Therapy
- First Posted Date
- 2006-06-12
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 291
- Registration Number
- NCT00335556
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of South Alabama, Mobile, Alabama, United States
Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma
- Conditions
- Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
- First Posted Date
- 2006-06-08
- Last Posted Date
- 2013-07-11
- Lead Sponsor
- Children's Oncology Group
- Registration Number
- NCT00334984
Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma
- Conditions
- Sarcoma
- Interventions
- Procedure: conventional surgeryProcedure: radiation therapy
- First Posted Date
- 2006-06-08
- Last Posted Date
- 2013-06-28
- Lead Sponsor
- Children's Oncology Group
- Registration Number
- NCT00334867
Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
- Conditions
- Neuroblastoma
- Interventions
- First Posted Date
- 2006-04-06
- Last Posted Date
- 2014-09-30
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 59
- Registration Number
- NCT00311584
- Locations
- 🇺🇸
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, United States
🇺🇸Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States
🇺🇸Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
- Conditions
- Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous LeukemiaChildhood Myelodysplastic SyndromesChronic Phase Chronic Myelogenous Leukemiade Novo Myelodysplastic SyndromesDisseminated NeuroblastomaJuvenile Myelomonocytic Leukemia
- Interventions
- Biological: etanercept
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 39
- Registration Number
- NCT00309907
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Children's Oncology Group, Arcadia, California, United States
🇺🇸Loma Linda University Medical Center, Loma Linda, California, United States